Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 493, doi. 10.1007/s00262-008-0571-9
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 4
Results: 14
1
2
Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8<sup>+</sup> T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 503, doi. 10.1007/s00262-008-0572-8
- By:
- Publication type:
- Article
3
In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 629, doi. 10.1007/s00262-008-0573-7
- By:
- Publication type:
- Article
4
Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 517, doi. 10.1007/s00262-008-0574-6
- By:
- Publication type:
- Article
5
Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 531, doi. 10.1007/s00262-008-0575-5
- By:
- Publication type:
- Article
6
Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 547, doi. 10.1007/s00262-008-0577-3
- By:
- Publication type:
- Article
7
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 553, doi. 10.1007/s00262-008-0578-2
- By:
- Publication type:
- Article
8
NK1.1<sup>+</sup> cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 575, doi. 10.1007/s00262-008-0581-7
- By:
- Publication type:
- Article
9
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 567, doi. 10.1007/s00262-008-0579-1
- By:
- Publication type:
- Article
10
Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 589, doi. 10.1007/s00262-008-0582-6
- By:
- Publication type:
- Article
11
High expression of PGE<sub>2</sub> enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 603, doi. 10.1007/s00262-008-0584-4
- By:
- Publication type:
- Article
12
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 615, doi. 10.1007/s00262-008-0586-2
- By:
- Publication type:
- Article
13
Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 475, doi. 10.1007/s00262-008-0598-y
- By:
- Publication type:
- Article
14
In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice